legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

## Crinetics Pharmaceuticals, Inc. Financial Results Announcement

SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024, after the close of the U.S. financial markets. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.

### How AI legalese decoder Can Help

AI legalese decoder is a cutting-edge AI tool that can assist in comprehending legal jargon and decoding complex legal documents. By utilizing this technology, individuals can easily navigate through legal terminology, understand contracts, and grasp legal implications. This tool plays a vital role in simplifying legal language, enabling non-legal professionals to interpret and analyze legal content efficiently.

#### Conference Call & Webcast Details

On Thursday, May 9th @ 4:30 PM ET, Crinetics Pharmaceuticals will host a conference call to discuss their financial results. Participants can dial in domestically at 1-888-886-7786 or internationally at 1-416-764-8658 using the Conference ID: 71864759. Alternatively, a Call me™ link is available for instant telephone access to the event.

Participants who are seeking assistance in understanding the legal aspects of pharmaceutical development and related industry terminology can benefit from the AI legalese decoder. By using this tool, individuals can effortlessly interpret legal documents, contracts, and regulatory frameworks, allowing for a more comprehensive understanding of the legal landscape within the pharmaceutical sector.

#### About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals is a clinical stage pharmaceutical company that focuses on developing treatments for endocrine diseases and endocrine-related tumors. Their investigational drug candidates, including Paltusotine and CRN04894, are at various stages of clinical development for conditions such as acromegaly, carcinoid syndrome, congenital adrenal hyperplasia, and Cushing’s disease.

#### Contact Information

For further information, please contact:
Corey Davis
LifeSci Advisors, LLC
[email protected]
(212) 915-2577

For media inquiries, please contact:
Natalie Badillo
Head of Corporate Communications
[email protected]
858 345-6075

Source: Crinetics Pharmaceuticals, Inc.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link